DBA/2 Mouse as an Animal Model for Anti-influenza Drug Efficacy Evaluation

Jin Il Kim; Sehee Park; Sangmoo Lee; Ilseob Lee; Jun Heo; Min-Woong Hwang; Joon-Yong Bae; Donghwan Kim; Seok-Il Jang; Mee Sook Park; Man-Seong Park

doi:10.1007/s12275-013-3428-7

Articles

Page Path: HOME > J. Microbiol > Volume 51(6); 2013 > Article

Research Support, Non-U.S. Gov't
DBA/2 Mouse as an Animal Model for Anti-influenza Drug Efficacy Evaluation: Jin Il Kim , Sehee Park , Sangmoo Lee , Ilseob Lee , Jun Heo , Min-Woong Hwang , Joon-Yong Bae , Donghwan Kim , Seok-Il Jang , Mee Sook Park , Man-Seong Park; Journal of Microbiology 2013;51(6):866-871.
DOI: https://doi.org/10.1007/s12275-013-3428-7
Published online: December 19, 2013

Department of Microbiology, Center for Medical Science Research, College of Medicine, Hallym University, Chuncheon 200-702, Republic of KoreaDepartment of Microbiology, Center for Medical Science Research, College of Medicine, Hallym University, Chuncheon 200-702, Republic of Korea

Corresponding author: Man-Seong Park , Tel: +82-33-248-2632,

Received: 9 August 2013 • Accepted: 3 September 2013

prev next

35 Views
0 Download
14 Crossref
17 Scopus

Full Article

Abstract

Influenza viruses are seasonally recurring human pathogens. Vaccines and antiviral drugs are available for influenza. However, the viruses, which often change themselves via antigenic drift and shift, demand constant efforts to update vaccine antigens every year and develop new agents with broad-spectrum antiviral efficacy. An animal model is critical for such efforts. While most human influenza viruses are unable to kill BALB/c mice, some strains have been shown to kill DBA/2 mice without prior adaptation. Therefore, in this study, we explored the feasibility of employing DBA/2 mice as a model in the development of anti-influenza drugs. Unlike the BALB/c strain, DBA/2 mice were highly susceptible and could be killed with a relatively low titer (50% DBA/2 lethal dose = 102.83 plaque-forming units) of the A/ Korea/01/2009 virus (2009 pandemic H1N1 virus). When treated with a neuraminidase inhibitor, oseltamivir phosphate, infected DBA/2 mice survived until 14 days postinfection. The reduced morbidity of the infected DBA/2 mice was also consistent with the oseltamivir treatment. Taking these data into consideration, we propose that the DBA/2 mouse is an excellent animal model to evaluate antiviral efficacy against influenza infection and can be further utilized for combination therapies or bioactivity models of existing and newly developed anti-influenza drugs.

Keywords: adaptation;animal model;antiviral;DBA/2 mouse;influenza virus

Figure & Data

References

Citations

Citations to this article as recorded by

Swine influenza A virus isolates containing the pandemic H1N1 origin matrix gene elicit greater disease in the murine model
Shelly J. Curran, Emily F. Griffin, Lucas M. Ferreri, Constantinos S. Kyriakis, Elizabeth W. Howerth, Daniel R. Perez, S. Mark Tompkins, Robert Paul de Vries
Microbiology Spectrum.2024;[Epub] CrossRef
Kinetic of the Antibody Response Following AddaVax-Adjuvanted Immunization with Recombinant Influenza Antigens
Ted. M. Ross, Naveen Gokanapudi, Pan Ge, Hua Shi, Robert A. Richardson, Spencer R. Pierce, Pedro Sanchez, Subhan Ullah, Eliana De Luca, Giuseppe A. Sautto
Vaccines.2022; 10(8): 1315. CrossRef
Peptidylarginine Deiminase 2 in Murine Antiviral and Autoimmune Antibody Responses
Aisha M. Mergaert, Michael F. Denny, Brock Kingstad-Bakke, Mandar Bawadekar, S. Janna Bashar, Thomas F. Warner, Marulasiddappa Suresh, Miriam A. Shelef, Baohui Xu
Journal of Immunology Research.2022; 2022: 1. CrossRef
The morphine/heroin vaccine decreased the heroin-induced antinociceptive and reinforcing effects in three inbred strains mouse
Susana Barbosa-Méndez, Maura Matus-Ortega, Ricardo Hernández-Miramontes, Alberto Salazar-Juárez
International Immunopharmacology.2021; 98: 107887. CrossRef
Animal models for the risk assessment of viral pandemic potential
Mee Sook Park, Jin Il Kim, Joon-Yong Bae, Man-Seong Park
Laboratory Animal Research.2020;[Epub] CrossRef
In Vivo Assessment of Antibody-Dependent Enhancement of Influenza B Infection
Gautham K Rao, Rodney A Prell, Steven T Laing, Stefanie C M Burleson, Allen Nguyen, Jacqueline M McBride, Crystal Zhang, Daniel Sheinson, Wendy G Halpern
Toxicological Sciences.2019; 169(2): 409. CrossRef
Targeting the proviral host kinase, FAK, limits influenza a virus pathogenesis and NFkB-regulated pro-inflammatory responses
Silke Bergmann, Husni Elbahesh
Virology.2019; 534: 54. CrossRef
Effects of heat-killed Lactobacillus plantarum against influenza viruses in mice
Sehee Park, Jin Il Kim, Joon-Yong Bae, Kirim Yoo, Hyunung Kim, In-Ho Kim, Man-Seong Park, Ilseob Lee
Journal of Microbiology.2018; 56(2): 145. CrossRef
Alternative Strategy for a Quadrivalent Live Attenuated Influenza Virus Vaccine
Zhimin Wan, Stivalis Cardenas Garcia, Jing Liu, Jefferson Santos, Silvia Carnaccini, Ginger Geiger, Lucas Ferreri, Daniela Rajao, Daniel R. Perez, Adolfo García-Sastre
Journal of Virology.2018;[Epub] CrossRef
PPARgamma Deficiency Counteracts Thymic Senescence
David Ernszt, Krisztina Banfai, Zoltan Kellermayer, Attila Pap, Janet M. Lord, Judit E. Pongracz, Krisztian Kvell
Frontiers in Immunology.2017;[Epub] CrossRef
Repeated Low-Dose Influenza Virus Infection Causes Severe Disease in Mice: a Model for Vaccine Evaluation
Yufeng Song, Xiang Wang, Hongbo Zhang, Xinying Tang, Min Li, Jufang Yao, Xia Jin, Hildegund C. J. Ertl, Dongming Zhou, D. S. Lyles
Journal of Virology.2015; 89(15): 7841. CrossRef
A broadly neutralizing human monoclonal antibody is effective against H7N9
Kannan Tharakaraman, Vidya Subramanian, Karthik Viswanathan, Susan Sloan, Hui-Ling Yen, Dale L. Barnard, Y. H. Connie Leung, Kristy J. Szretter, Tyree J. Koch, James C. Delaney, Gregory J. Babcock, Gerald N. Wogan, Ram Sasisekharan, Zachary Shriver
Proceedings of the National Academy of Sciences.2015; 112(35): 10890. CrossRef
Anti-influenza effect of Cordyceps militaris through immunomodulation in a DBA/2 mouse model
Hwan Hee Lee, Heejin Park, Gi-Ho Sung, Kanghyo Lee, Taeho Lee, Ilseob Lee, Man-seong Park, Yong Woo Jung, Yu Su Shin, Hyojeung Kang, Hyosun Cho
Journal of Microbiology.2014; 52(8): 696. CrossRef
Combination Effects of Peramivir and Favipiravir against Oseltamivir-Resistant 2009 Pandemic Influenza A(H1N1) Infection in Mice
Sehee Park, Jin Il Kim, Ilseob Lee, Sangmoo Lee, Min-Woong Hwang, Joon-Yong Bae, Jun Heo, Donghwan Kim, Seok-Il Jang, Hyejin Kim, Hee Jin Cheong, Jin-Won Song, Ki-Joon Song, Luck Ju Baek, Man-Seong Park, Balaji Manicassamy
PLoS ONE.2014; 9(7): e101325. CrossRef

Cite this Article

Cite this Article: export Copy Download Format; Close

Download Citation

Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

Format:

RIS — For EndNote, ProCite, RefWorks, and most other reference management software
BibTeX — For JabRef, BibDesk, and other BibTeX-specific software

Include:

Citation for the content below
Citation and abstract for the content below

DBA/2 Mouse as an Animal Model for Anti-influenza Drug Efficacy Evaluation

J. Microbiol. 2013;51(6):866-871. Published online December 19, 2013

DOI: https://doi.org/10.1007/s12275-013-3428-7

Related articles